Post by Biogen
1,300,802 followers
AI and digital twin approaches are becoming important tools across R&D—helping teams analyze complex datasets and explore disease biology in new ways to potentially accelerate drug development. Our partnership with Aitia is one example of how we’re applying these approaches, using digital twin and causal AI to support biomarker discovery and translational insights into our research on Huntington’s disease. Learn more about how we’re advancing R&D at Biogen: http://spr.ly/6040BEHupk
Video Content